Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

ViaCell

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Medium growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Boston, Massachusetts, United States Founded 1993 11-50 employees For Profit

ViaCell is a biotechnology company focused on the area of women’s health.

ViaCell on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

ViaCell was acquired by PerkinElmer in 2007 for $300M.
Total Funding
$68M
Funding Rounds
2
Last Funding
Acquisitions
1
Monthly Visits
Contacts
53

About ViaCell

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Delisted
Ticker
VIAC
Exchange
NASDAQ
IPO date
Jan 21, 2005
Raised at IPO
$53M
Valuation at IPO
$252M
Delisted
Nov 15, 2007

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
36
Mobile apps
1
Active products
32
IT spend
$96.43K

Company Info

Founded
1993
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
2
HQ
Boston, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England
Diversity spotlight
Women Founded
Exit date
Jan 21, 2005

Signals & Scores

Heat score
Medium
Growth score
Medium
Trend (7d)
1.5
Trend (30d)
4.6
Trend (90d)
5.2

ViaCell Funding Rounds

2 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesInvestor NamesFunding StageOrg IndustriesOrg Hq CityOrg Hq CountryOrg DescriptionOrg Number Of EmployeesOrg Website
1–2 of 2Show
Page 1 / 1

ViaCell Acquisitions

1 results
Acquiree NameAcquirer NameAcquisition TypeAcquisition TermsAcquiree IndustriesAcquiree Hq CityAcquiree Hq CountryAcquiree DescriptionAcquiree Number Of EmployeesAcquirer IndustriesAcquirer Hq CountryAcquirer Number Of EmployeesAcquirer Ipo StatusAcquiree Website
Kourion Therapeutics2003-11-11ViaCellAcquisitionBiotechnologyHealth CareTherapeuticsDüsseldorfGermanyKourion Therapeutics is developing cell therapies for the tr2001-01-0111-50BiotechnologyHealth CareMedicalUnited States11-50Delisted1www.kourion.de
1–1 of 1Show
Page 1 / 1
53
professional contacts at ViaCell
Contact execs at ViaCell

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to ViaCell

Loading news…

FAQs about ViaCell

People who checked this page also checked these

Sectors ViaCell invests & acquires in

M&A by year

Browse the full Acquirezy directory.